Clinical contraindications to allergen immunotherapy: an EAACI position paper
Clinical indications for allergen immunotherapy (AIT) in respiratory and Hymenoptera venom
allergy are well established; however, clinical contraindications to AIT are not always well …
allergy are well established; however, clinical contraindications to AIT are not always well …
Anaphylaxis: a review of causes and mechanisms
SF Kemp, RF Lockey - Journal of allergy and clinical immunology, 2002 - Elsevier
Anaphylaxis is a life-threatening syndrome resulting from the sudden release of mast cell-
and basophil-derived mediators into the circulation. Foods and medications cause most …
and basophil-derived mediators into the circulation. Foods and medications cause most …
Anaphylaxis—a practice parameter update 2015
P Lieberman, RA Nicklas, C Randolph… - Annals of Allergy …, 2015 - annallergy.org
This is the fourth iteration of this parameter entitled “The Diagnosis and Management of
Anaphylaxis.” The first anaphylaxis parameter was published in 1998 and the last in 2010 …
Anaphylaxis.” The first anaphylaxis parameter was published in 1998 and the last in 2010 …
The diagnosis and management of anaphylaxis practice parameter: 2010 update
P Lieberman, RA Nicklas, J Oppenheimer… - Journal of Allergy and …, 2010 - Elsevier
These parameters were developed by the Joint Task Force on Practice Parameters,
representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the …
representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the …
Emergency department diagnosis and treatment of anaphylaxis: a practice parameter
RL Campbell, JTC Li, RA Nicklas… - Annals of Allergy, Asthma …, 2014 - annallergy.org
A search of the medical literature was performed for different terms that were considered
relevant to this practice parameter. Literature searches were performed on PubMed and the …
relevant to this practice parameter. Literature searches were performed on PubMed and the …
Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice
F Bonifazi, M Jutel, BM Biló, J Birnbaum, U Muller… - Allergy, 2005 - Wiley Online Library
Based on the knowledge of the living conditions and habitat of social Aculeatae a series of
recommendations have been formulated which can potentially greatly minimize the risk of …
recommendations have been formulated which can potentially greatly minimize the risk of …
The diagnosis and management of anaphylaxis: an updated practice parameter
P Lieberman, SF Kemp, J Oppenheimer… - Journal of Allergy and …, 2005 - Elsevier
These parameters were developed by the Joint Task Force on Practice Parameters,
representing the American Academy of Allergy, Asthma and Immunology; the American …
representing the American Academy of Allergy, Asthma and Immunology; the American …
Anaphylaxis: mechanisms and management
JK Lee, P Vadas - Clinical & Experimental Allergy, 2011 - Wiley Online Library
Anaphylaxis is a serious allergic reaction that can be rapid in onset and occasionally fatal.
This is a review of the literature on the epidemiology of anaphylaxis, diagnostic criteria …
This is a review of the literature on the epidemiology of anaphylaxis, diagnostic criteria …
Use of β-blockers during immunotherapy for Hymenoptera venom allergy
UR Müller, G Haeberli - Journal of Allergy and Clinical Immunology, 2005 - Elsevier
BACKGROUND: B-Blockers may aggravate anaphylactic reactions and interfere with
treatment. There is therefore concern about their use in patients who have a history of …
treatment. There is therefore concern about their use in patients who have a history of …
Increased risk for anaphylactoid reaction from contrast media in patients on β-adrenergic blockers or with asthma
DM Lang, MB Alpern, PF Visintainer… - Annals of internal …, 1991 - acpjournals.org
▪ Objective: To determine whether greater risk for anaphylactoid reaction from intravenous
urographic contrast media exists in patients receiving β-adrenergic blockers or in asthmatic …
urographic contrast media exists in patients receiving β-adrenergic blockers or in asthmatic …